{"id":859007,"date":"2025-06-10T09:04:49","date_gmt":"2025-06-10T13:04:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/"},"modified":"2025-06-10T09:04:49","modified_gmt":"2025-06-10T13:04:49","slug":"oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/","title":{"rendered":"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SARASOTA, Fla., June  10, 2025  (GLOBE NEWSWIRE) &#8212; Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present at the 2025 BIO International Convention, taking place June 16\u201319, 2025, in Boston, Massachusetts. In addition, Oragenics will also attend the 42nd Annual National Neurotrauma Society (NNS) Symposium, being held June 15\u201318, 2025, in Philadelphia, Pennsylvania.<\/p>\n<p>These back-to-back events represent key opportunities for Oragenics to highlight its lead candidate, ONP-002, an intranasal neurosteroid in development for the treatment of concussion (mild traumatic brain injury), and to engage with global leaders in neuroscience, neurology, biotech, and pharma.<\/p>\n<p>\n        <strong>2025 BIO International Convention<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt\">\n          <strong>Dates:<\/strong> June 16\u201319, 2025<\/li>\n<li>\n          <strong>Location:<\/strong> Boston Convention &amp; Exhibition Center, Boston, MA<\/li>\n<li>\n          <strong>Presentation Date &amp; Time:<\/strong> June 19, 2025, from 11:30 AM \u2013 11:45 AM ET<\/li>\n<li style=\"margin-bottom:12pt\">\n          <strong>Registration:<\/strong><br \/>\n          <a href=\"https:\/\/www.bio.org\/events\/bio-international-convention\/registration\" rel=\"nofollow\" target=\"_blank\"><br \/>\n            <u>https:\/\/www.bio.org\/events\/bio-international-convention\/registration<\/u><br \/>\n            <br \/>\n          <\/a>\n        <\/li>\n<\/ul>\n<p>\n        <strong>42nd Annual National Neurotrauma Society (NNS) Symposium<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:12pt\">\n          <strong>Dates:<\/strong> June 15\u201318, 2025<\/li>\n<li>\n          <strong>Location:<\/strong> Philadelphia Marriott Downtown, Philadelphia, PA<\/li>\n<li style=\"margin-bottom:12pt\">\n          <strong>Co-hosts:<\/strong> National Neurotrauma Society and AANS\/CNS Joint Section on Neurotrauma &amp; Critical Care<\/li>\n<\/ul>\n<p>\n        <strong>About Oragenics, Inc.<\/strong><br \/>\n        <br \/>Oragenics is a biotechnology company focused on developing intranasal therapeutics for neurological disorders. Its lead candidate, ONP-002, is being developed for the treatment of mild traumatic brain injury (mTBI), commonly known as concussion. The Company\u2019s intranasal delivery technology is designed to deliver fast, targeted, and non-invasive therapy to the brain. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cL0YQVpP2-Iwm-7gmn6Hsesh4U2ywQW2Dw0pGU1pbt1N7QCw3KU_nWG6XiEhqe4alhFRL-aD0MPW3rf2lPnOw1ABGrNwWt_xnyembqhdYEg=\" rel=\"nofollow\" target=\"_blank\"><u>www.oragenics.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Rich Cockrell<br \/>CG Capital<br \/>866.889.1972<br \/>ogen@cg.capital<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmU1MzJhNjMtNWU2ZC00Njc1LTk0NGMtOWU3MWRhZTc4YmVjLTEyMTMyOTAtMjAyNS0wNi0xMC1lbg==\/tiny\/Oragenics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) &#8212; Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present at the 2025 BIO International Convention, taking place June 16\u201319, 2025, in Boston, Massachusetts. In addition, Oragenics will also attend the 42nd Annual National Neurotrauma Society (NNS) Symposium, being held June 15\u201318, 2025, in Philadelphia, Pennsylvania. These back-to-back events represent key opportunities for Oragenics to highlight its lead candidate, ONP-002, an intranasal neurosteroid in development for the treatment of concussion (mild traumatic brain injury), and to engage with global leaders in neuroscience, neurology, biotech, and pharma. 2025 BIO International Convention Dates: June 16\u201319, 2025 Location: Boston Convention &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-859007","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) &#8212; Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present at the 2025 BIO International Convention, taking place June 16\u201319, 2025, in Boston, Massachusetts. In addition, Oragenics will also attend the 42nd Annual National Neurotrauma Society (NNS) Symposium, being held June 15\u201318, 2025, in Philadelphia, Pennsylvania. These back-to-back events represent key opportunities for Oragenics to highlight its lead candidate, ONP-002, an intranasal neurosteroid in development for the treatment of concussion (mild traumatic brain injury), and to engage with global leaders in neuroscience, neurology, biotech, and pharma. 2025 BIO International Convention Dates: June 16\u201319, 2025 Location: Boston Convention &hellip; Continue reading &quot;Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T13:04:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium\",\"datePublished\":\"2025-06-10T13:04:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/\"},\"wordCount\":246,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/\",\"name\":\"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=\",\"datePublished\":\"2025-06-10T13:04:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Market Newsdesk","og_description":"SARASOTA, Fla., June 10, 2025 (GLOBE NEWSWIRE) &#8212; Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced that Greg Gironda, Head of Business Development, will present at the 2025 BIO International Convention, taking place June 16\u201319, 2025, in Boston, Massachusetts. In addition, Oragenics will also attend the 42nd Annual National Neurotrauma Society (NNS) Symposium, being held June 15\u201318, 2025, in Philadelphia, Pennsylvania. These back-to-back events represent key opportunities for Oragenics to highlight its lead candidate, ONP-002, an intranasal neurosteroid in development for the treatment of concussion (mild traumatic brain injury), and to engage with global leaders in neuroscience, neurology, biotech, and pharma. 2025 BIO International Convention Dates: June 16\u201319, 2025 Location: Boston Convention &hellip; Continue reading \"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-10T13:04:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium","datePublished":"2025-06-10T13:04:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/"},"wordCount":246,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/","name":"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=","datePublished":"2025-06-10T13:04:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ2NTkyNyM2OTgzMTkzIzIyMDE3Mzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/oragenics-to-present-at-2025-bio-international-convention-and-attend-42nd-annual-national-neurotrauma-society-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=859007"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/859007\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=859007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=859007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=859007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}